5th International Caparica Conference in Antibiotic Resistance 2022
05th – 08th September 2022 | Caparica | Portugal
Dear Colleagues and friends
It is with great pleasure that we announce the upcoming international conference on Antibiotic Resistance, to be held in the Caparica, Portugal on 05th – 08th September 2022.
In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary.
The use of antibiotics constitutes an important factor for selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility in therapeutic failure.
Appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us to control totally this problem. In this conference an attempt has been made to present the latest research on possibilities to manage this question.
The primary objective of this meeting is to bring together researchers involved in antibiotic resistance prevention and control. The meeting will take an integrated approach to research and it will bring about researchers specializing in different subjects related to antibiotic resistance. We expected to present a universal vision of the importance of antimicrobial resistance in different ecosystems and what can be done about it.
During diverse sessions, all aspects related to epidemiology of resistance in animal and zoonotic pathogens, mobile elements containing resistance genes, proteomics of antimicrobial resistance, emerging antimicrobial resistance mechanisms, control of resistant infections, antimicrobial resistance in animal pathogens and its exchange with humans, organizing antibiotic surveillance, policies to stimulate drug development and discovery and alternatives strategies to overcome the problem of antimicrobial resistance worldwide will be discussed.
J. L. Capelo
On behalf of the organizing and scientific committee
Karen Bush, PhD
Affiliation: Indiana University Bloomington (USA)
David Livermore, PhD
Affiliation: Norwich Medical School, University of East Anglia, Norwich (UK)
Title: Antibiotic resistance challenges in a world with endemic COVID-19.
Patrice Courvalin, PhD
Affiliation: Department of Microbiology, Institut Pasteur (France)
Alessandra Carattoli, PhD
Affiliation: Faculty of Medicine and Farmacology, Sapienza University of Rome (Italy)
Title: Plasmids and the spread of antibiotic resistance.
Fernando Baquero, PhD
Affiliation: Department of Microbiology, Ramón y Cajal University Hospital (Spain)
Title: Microbial ecology of built surfaces at the intensive care unit.
John Elmerdahl Olsen, PhD
Affiliation: Department of Veterinary and Animal Sciences, University of Copenhagen (Denmark)
Title: Targeting the secondary resistome in bacteria – a possible way to re-sensitize resistant bacteria to treatment with current drugs.
Olga Lomovskaya, PhD
Affiliation: Senior Vice President, Discovery and Clinical Microbiology, Qpex Biopharma (USA)
Patrícia Poeta, PhD
Affiliation: University of Trás-os-Montes and Alto Douro, Vila Real (Portugal)
Title: The One Health concept: a Long Road Ahead
Rolf Muller, PhD
Affiliation: Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Department of Pharmacy at Saarland University (Germany)
Title: Approaches towards innovative antibiotics from soil bacteria.
Rachel Powers, PhD
Affiliation: Department of Chemistry, Grand Valley State University (USA)
Title: Structure-Based Discovery and Optimization of Inhibitors for the Class D β-Lactamase OXA-24/40.
Stefan Schwarz, PhD
Affiliation: Centre of Infection Medicine Department of Veterinary Medicine Freie, Universität Berlin Robert-von-Ostertag-Str, Berlin (Germany)
Title: Mobile oxazolidinone resistance genes and their dissemination among Gram-positive and Gram-negative bacteria.
Marvin Whiteley, PhD
Affiliation: Georgia Institute of Technology, Georgia (USA)
Title: Using bacterial human infection transcriptomes to guide pre-clinical model development and antimicrobial discovery
Bruno Gonzalez-Zorn, DVM, PhD
Affiliation: Complutense University of Madrid (Spain)
Title: Antimicrobial Resistance and One Health
Laurent Poirel, PhD
Affiliation: Faculty of Science and Medicine, University of Fribourg (Switzerland)
Title: Recent developments on beta-lactam / beta-lactamase inhibitor combinations; mode of action and mechanisms of resistance.
Christina Vandenbroucke-Grauls, PhD
Affiliation: Amsterdam University Medical Centers (The Netherlands)
Title: Avaliable soon.
Tatiana Pinto, PhD
Affiliation: Federal University of Rio de Janeiro (Brazil)
Title: Increasing occurrence of multidrug-resistant bacteria colonization among pregnant women in Brazil after the onset of COVID-19 pandemic.
Emilia Caselli, PhD
Affiliation: University of Modena and Reggio Emilia (Italy)
Title: Sulfonamidoboronic acids as cross-class inhibitors of ADC-33 and OXA-24/40 beta-lactamases to combat resistance in A. baumannii
Matthias Tacke, PhD
Affiliation: University College Dublin (Ireland)
Title: SBC3 – A Novel Silver-Based Antibiotic Drug Candidate against Resistant Bacteria and Fungi.
Elisabeth Grohmann, PhD
Affiliation: Beuth University of Applied Sciences Berlin (Germany)
Title: Thermophilic composting of human excreta: Microbial community shifts and decline of antimicrobial resistance
Simonetta Grilli, PhD
Affiliation: Institute of Applied Sciences and Intelligent Systems (Italy)
Title: The Biofilm Electrostatic Test: a new platform for rapid evaluation of biofilm formation.
Dilip Shah, PhD
Affiliation: Donald Danforth Plant Science Center, St. Louis (USA)
Eric T. Harvill, PhD
Affiliation: Department of Infectious Diseases, University of Georgia, Athens (USA)
Title: Natural history, ecology and antibiotics in model respiratory and middle ear pathogens.
Baltasar Mayo, PhD
Affiliation: IPLA-CSIC (Spain)
Title: Antibiotic resistance of lactic acid bacteria and bifidobacteria from dairy and human sources.
Zvi Hayouka, PhD
Affiliation: Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem (Israel)
Title: Development of novel “resistance proof” antimicrobial peptides.
Elena Gomez Sanz, PhD
Affiliation: ETH Zurich, Institute of Food, Nutrition and Health (IFNH), Laboratory of Food Microbiology (Switzerland)
Title: Multispecies host range of staphylococcal phages isolated from wastewater
Robert A. Bonomo, PhD
Affiliation: Case Western Reserve University, School of Medicine (USA)
Title: The Renaissance of beta-lactamase Inhibitors
Title: Avaliable soon.
- Rise of Antimicrobial Resistance and Epidemiology: Concerns on Pathogen Resistance and Public Health
- A public health approach to antimicrobial Resistance
- Genetics of antimicrobial resistance
- Proteomics of antimicrobial resistance
- The emergence of antimicrobial resistance in animals
- Antimicrobial resistance in animal pathogens and its exchange with humans
- How antimicrobial resistance may be affected by the use of antibiotics in food and agriculture
- Mechanisms of Antibacterial Resistance
- Organizing antibiotic surveillance
- Policies to stimulate drug development and discovery
- Alternative Strategies to overcome the problem of antimicrobial resistance worldwide
- Control of resistant infections
Hotel TRYP Lisboa Caparica Mar
Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of IC2AR 2022 is working with CHS
We look forward to seeing you soon.
With kindest regards
The BIOSCOPE Team